TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy
Binfeng Yu, Lini Jin, Xi Yao, Yi Zhang, Gensheng Zhang, Fangqin Wang, Xinwan Su, Qiuyuan Fang, Xiao Liang, Yi Yang, Lin‐Hua Jiang, Jianghua Chen, Wei Yang, Weiqiang Lin, Fei Han
Abstract
-AKT-mTOR signaling pathway and autophagy, providing novel insights into the pathogenesis of kidney injury.
Topics & Concepts
AutophagyTRPM2CisplatinPI3K/AKT/mTOR pathwayNephrotoxicityProtein kinase BCancer researchMitochondrionAcute kidney injuryProgrammed cell deathApoptosisOxidative stressPharmacologyChemistryCell biologyKidneyMedicineBiologyTransient receptor potential channelEndocrinologyInternal medicineReceptorBiochemistryChemotherapyChemotherapy-induced organ toxicity mitigationDialysis and Renal Disease ManagementAcute Kidney Injury Research